PMC:7199903 / 266-635 JSONTXT 15 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T39 8-13 NN denotes spike
T40 14-17 VBZ denotes has
T41 18-20 CD denotes 22
T42 21-34 NN denotes glycosylation
T43 35-40 NNS denotes sites
T44 42-45 WRB denotes How
T45 46-51 DT denotes these
T46 52-57 NNS denotes sites
T47 58-61 VBP denotes are
T48 62-74 VBN denotes glycosylated
T49 75-78 MD denotes may
T50 79-85 VB denotes affect
T51 86-91 WDT denotes which
T52 92-97 NNS denotes cells
T53 98-101 DT denotes the
T54 102-107 NN denotes virus
T55 108-111 MD denotes can
T56 112-118 VB denotes infect
T57 119-122 CC denotes and
T58 123-128 MD denotes could
T59 129-135 VB denotes shield
T60 136-140 DT denotes some
T61 141-149 NNS denotes epitopes
T62 150-154 IN denotes from
T63 155-163 NN denotes antibody
T64 164-178 NN denotes neutralization
T65 180-188 NNP denotes Watanabe
T66 189-191 FW denotes et
T67 192-195 FW denotes al.
T68 196-205 VBN denotes expressed
T69 206-209 CC denotes and
T70 210-218 VBN denotes purified
T71 219-230 JJ denotes recombinant
T72 231-243 VBN denotes glycosylated
T73 244-249 NN denotes spike
T74 250-257 NNS denotes trimers
T75 257-258 -COMMA- denotes ,
T76 259-270 VBD denotes proteolysed
T77 271-275 PRP denotes them
T78 276-278 TO denotes to
T79 279-284 VB denotes yield
T80 285-298 NNS denotes glycopeptides
T81 299-309 VBG denotes containing
T82 310-311 DT denotes a
T83 312-318 JJ denotes single
T84 319-325 NN denotes glycan
T85 325-326 -COMMA- denotes ,
T86 327-330 CC denotes and
T87 331-341 VBD denotes determined
T88 342-345 DT denotes the
T89 346-357 NN denotes composition
T90 358-360 IN denotes of
T91 361-364 DT denotes the
R38 T43 T40 arg2Of sites,has
R39 T43 T41 arg1Of sites,22
R40 T43 T42 arg1Of sites,glycosylation
R41 T48 T44 arg1Of glycosylated,How
R42 T46 T45 arg1Of sites,these
R43 T46 T47 arg1Of sites,are
R44 T48 T47 arg2Of glycosylated,are
R45 T46 T48 arg2Of sites,glycosylated
R46 T44 T49 arg1Of How,may
R47 T50 T49 arg2Of affect,may
R48 T44 T50 arg1Of How,affect
R49 T51 T50 arg2Of which,affect
R50 T52 T51 arg1Of cells,which
R51 T54 T53 arg1Of virus,the
R52 T54 T55 arg1Of virus,can
R53 T56 T55 arg2Of infect,can
R54 T54 T56 arg1Of virus,infect
R55 T52 T56 arg2Of cells,infect
R56 T50 T57 arg1Of affect,and
R57 T59 T57 arg2Of shield,and
R58 T44 T58 arg1Of How,could
R59 T59 T58 arg2Of shield,could
R60 T44 T59 arg1Of How,shield
R61 T61 T59 arg2Of epitopes,shield
R62 T61 T60 arg1Of epitopes,some
R63 T61 T62 arg1Of epitopes,from
R64 T64 T62 arg2Of neutralization,from
R65 T64 T63 arg1Of neutralization,antibody
R66 T74 T65 arg1Of trimers,Watanabe
R67 T67 T66 arg1Of al.,et
R68 T65 T67 arg1Of Watanabe,al.
R69 T67 T68 arg2Of al.,expressed
R70 T68 T69 arg1Of expressed,and
R71 T70 T69 arg2Of purified,and
R72 T67 T70 arg2Of al.,purified
R73 T74 T71 arg1Of trimers,recombinant
R74 T74 T72 arg2Of trimers,glycosylated
R75 T74 T73 arg1Of trimers,spike
R76 T86 T75 arg1Of and,","
R77 T74 T76 arg1Of trimers,proteolysed
R78 T77 T76 arg2Of them,proteolysed
R79 T79 T76 arg3Of yield,proteolysed
R80 T79 T78 arg1Of yield,to
R81 T77 T79 arg1Of them,yield
R82 T80 T79 arg2Of glycopeptides,yield
R83 T80 T81 arg1Of glycopeptides,containing
R84 T84 T81 arg2Of glycan,containing
R85 T84 T82 arg1Of glycan,a
R86 T84 T83 arg1Of glycan,single
R87 T86 T85 arg1Of and,","
R88 T76 T86 arg1Of proteolysed,and
R89 T87 T86 arg2Of determined,and
R90 T74 T87 arg1Of trimers,determined
R91 T89 T87 arg2Of composition,determined
R92 T89 T88 arg1Of composition,the
R93 T89 T90 arg1Of composition,of